Clinical Decision Support Systems Market Analysis

Clinical Decision Support System Market Overview

Clinical Decision Support System Market size was valued at USD 3.27 billion in 2023. The clinical decision support system market industry is projected to grow from USD 3.67 Billion in 2024 to USD 8.92 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.54% during the forecast period (2023 - 2032). The rising geriatric population, favorable government regulations, and growing demand for data-driven technologies are driving market growth.

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Clinical Decision Support System Market Trends

The rising geriatric population boosts market growth.

The geriatric population is more prone to chronic diseases and requires frequent medical checkups and treatments. Thus, with the increasing geriatric population, the burden on healthcare institutions also increases. This increases the demand for technologies such as CDSS to provide efficient care. For instance, according to the UN, by 2050, 1 in 6 people around the globe will be over the age of 65, up from 1 in 11 in 2019. According to the Rural Health Information Hub, in the US, the number of older adults aged 65 and older is expected to grow to almost 90 million by 2050. In addition, by 2030, 1 in 5 Americans is projected to be 65 years old or over.

Furthermore, according to the UK parliament, around one-fifth of the UK population (19%), or around 12.3 million people, was aged 65 or over in 2019. Also, according to the Population Reference Bureau, in 2019, 28% of Japan's population is aged 65 or above, followed by Italy at 23%. Therefore, the increasing geriatric population trend can be seen globally and can be considered a major factor driving the growth of the market.

Clinical Decision Support System Market Segment Insights

Clinical Decision Support System Component Insights

The Clinical Decision Support System Market segmentation, based on component, includes software, services, and hardware. The software segment held the majority share in 2023 in the Clinical Decision Support System Market revenue. This is due to the rising healthcare cost, intense desire to enhance treatment quality. Moreover, CDSS software can provide healthcare providers with recommendations for diagnosis, treatment options, and preventive care based on the latest clinical guidelines and evidence.

CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Clinical Decision Support System Product Insights

The Clinical Decision Support System Market segmentation is based on product that include Integrated CDSS and Standalone CDSS. The Integrated CDSS segment has dominated the market in 2023 and is projected to be the fastest-growing segment during the forecast period, 2024-2032. This is attributed to factors such as the rapid shift of healthcare industries towards integrated solutions and rising pressure to improve patient outcomes and reduce healthcare costs.

Clinical Decision Support System Model Insights

The Clinical Decision Support System Market segmentation is based on a model that includes Knowledge-Based CDSS and Non-Knowledge-Based CDSS. The knowledge-based CDSS model segment has dominated the market in 2023. This is due to its selective advantages over the non-knowledge-based devices.

Clinical Decision Support System Delivery Mode Insights

The Clinical Decision Support System Market segmentation is based on delivery mode that includes On-Premise CDSS and Cloud-Based CDSS. The On-Premise CDSS segment has dominated the market in 2023 and the Cloud-Based CDSS segment is projected to be the fastest-growing segment during the forecast period, 2023-2032. This is due to the growing need for data integration and interoperability. However, the high setup and maintenance costs will hamper the on-premises CDSS segment’s growth in the coming years.

April 2021: Cerner Corporation (US) acquired Kantar Health (US), a Kantar Group division, for USD 375 Million. The combination of Kantar Health's extensive life sciences experience with Cerner's large selection of real-world data (RWD) and technology is anticipated to accelerate life sciences research innovation and improve patient outcomes globally.

Clinical Decision Support System Mode of Advice Insights

The Clinical Decision Support System Market segmentation is based on mode of advice that includes Active CDSS and Passive CDSS. The active CDSS segment has dominated the market in 2023 and the Cloud-Based CDSS segment is projected to be the fastest-growing segment during the forecast period, 2023-2032. This is due to the growing adoption rates by clinicians and hospitals, and advances in technology and artificial intelligence (AI).

Clinical Decision Support System Setting Insights

The Clinical Decision Support System Market segmentation is based on setting that includes inpatient settings and ambulatory care settings. The inpatient settings segment has dominated the market in 2023. This is due to the growing geriatric population, high demand for medication order entry and patient scheduling.

Clinical Decision Support System Type Insights

The Clinical Decision Support System Market segmentation is based on type that include therapeutic clinical decision support systems and diagnostic clinical decision support systems. The therapeutic clinical decision support systems segment has dominated the market in 2023. This is owing to the adoption rate by physicians and their ability to transform clinical health practices by providing a user interface with therapeutic best practices rather than only offering diagnostic support.

Clinical Decision Support System Application insights

The Clinical Decision Support System Market segmentation is based on application that include advanced clinical decision support systems and conventional clinical decision support systems. The advanced clinical decision support systems segment has dominated the market in 2023. This is attributed to users opting to upgrade CDSS systems, including premium functions such as treatment planning protocol, population health management, protocol validation, patient record management, reasoning-based models, and health economics management.

July 2020: Cerner Corporation, (US) partnered with Holon Solutions (US), is a healthcare information technology company. This partnership provides advanced clinical decision support technology for improved patient outcomes.

Clinical Decision Support System Regional Insights

By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North America clinical decision support system market accounted for the largest market share in 2023. This is due to the increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, diabetes, obesity, and arthritis in the North American region. In 2020, as per the National Cancer Institute, the National Institutes of Health forecasted an estimated 1,806,590 new cases of cancer to be diagnosed in the US, with about 606,520 deaths reported as a result of the disease. Additionally, the Centers for Disease Control and Prevention has estimated in 2021 that about 659,000 people die of heart diseases in the US every year. Moreover, the rise in the technological advancement in CDSS, surging demand for healthcare information technology solutions, and high awareness rate among patients in the region drive the regional market growth during the forecast period.

Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY REGION 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Europe clinical decision support system market accounts for the second-largest market share due to accessibility to advanced treatment facilities in the region. further, Germany clinical decision support system market was attributed to hold the largest market share, and the UK clinical decision support system market is expected to fastest-growing market in the European region.

The Asia-Pacific clinical decision support system market is expected to grow at a significant share from 2024 to 2032. This is due to factors such as improving healthcare infrastructure and the increasing patient population suffering from chronic diseases such as cancer, orthopedic, and cardiovascular diseases in the Asia-Pacific region. Moreover, China clinical decision support system market is expected to hold the largest market share, and India clinical decision support system market is expected fastest-growing market in the Asia-Pacific region.

Furthermore, as per the data published by The World Bank Group, in 2020, the incidence of tuberculosis in the Central African Republic was 540 per 100,000 people, which is high compared to the global average incidence rate of 127 per 100,000 people. Hence, the rise in chronic disorders such as HIV and tuberculosis drives growth in the region for the clinical decision support system market.

The Rest of the World is segmented into the Middle East, Africa, and Latin America. The clinical decision support system market in the above-mentioned regions is likely to witness growth due to technological advancements in CDSS, and growing investment in e-Health infrastructure in the region. Moreover, the Middle East & Africa has a huge opportunity for market growth due to the rising geriatric population and prevalence of cardiovascular and neurological disorders, which requires integrated services. So, major market players are taking initiatives to increase their market share in this region.

Clinical Decision Support System Key Market Players & Competitive Insights

The Clinical Decision Support System Market is characterized by the presence of many global, regional, and local vendors. Developments in the healthcare industry and growing research and development make the clinical decision support system market lucrative. To expand their reach and optimize their operational costs, the major players focus on obtaining regulatory authorizations from government agencies for their products and emphasize acquisitions and product launches to gain a substantial market share. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reach across the globe with diverse product portfolios. Companies such as Siemens (Germany), Veradigm LLC (Allscripts Healthcare Solutions Inc) (US), Oracle Corporation (US), and IBM (US) dominate the Clinical Decision Support System Market due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are focused on investing in research and development. Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.

One of the primary business strategies adopted by manufacturers in the global Clinical decision support system industry to benefit clients and expand the clinical decision support system market sector is to manufacture locally to reduce operating costs.

Siemens (Germany) is a technology-driven company that focuses on developing innovative products. It has a strong distribution network and offers its products to more than five million patients worldwide. The company has a strong network and presence in over 200 countries. It also offers a range of automation solutions in its product portfolio via several subsidiaries. The company is providing clinical decision support system through Siemens Healthineers. For instance, in December 2020, Veradigm LLC (Allscripts Healthcare Solutions Inc) announced the Sunrise 20.0. Sunrise is a health-care platform that connects all aspects of care, including acute, ambulatory, surgical, pharmacy, radiology, and laboratory services, as well as an integrated revenue cycle and patient administration system. Sunrise is a clinician-friendly, evidence-based single platform with integrated analytics that aids in the delivery of better health outcomes in hospitals around the world.

Also, Veradigm LLC (Allscripts healthcare solutions inc) (US) is a leader in healthcare information technology solutions that provide advanced clinical, financial, and operational results to clients. It offers comprehensive solutions in the healthcare industry designed to help clients improve the quality and efficiency of healthcare services by providing Electronic Health Records (EHR), financial management, population health management, and precise medicine/consumer solutions. The company has a global presence across the US, Australia, India, Canada, Singapore, Israel, and the UK. Furthermore, in January 2023, Allscripts Healthcare Solutions, Inc. has announced that, it has changed its name to Veradigm Inc.

Key Companies in the Clinical Decision Support System Market include

• Siemens (Germany)


• Veradigm LLC (Allscripts Healthcare Solutions Inc) (US)


• Oracle Corporation (US)


• IBM (US)


• Carestream Health (US)


• Wolters Kluwer N.V. (Netherlands)


• Epic Systems Corporation (US)


• Chang Healthcare (US)


• Medical Information Technology, Inc. (US)


• Computer Programs and Systems, Inc (US)

Clinical Decision Support System Industry Developments

January 2021: Cerner Corporation (US) collaborated with American Hospital Dubai, a part of Mohamed & Obaid Al Mulla Group (UAE), to develop Artificial Intelligence (AI) based models to develop the healthcare sector in UAE.

March 2020: IBM (US) Watson Health and EBSCO Information Services collaborated to launch integrated clinical decision support solution.

March 2019: Veradigm LLC (Allscripts Healthcare Solutions Inc) (US) collaborated with Alfardan Group (Qatar) and Northwestern Medicine (US) to provide EMR solutions to ambulatory care services across the Middle East.

Clinical Decision Support System Market Segmentation

Clinical Decision Support System Component Outlook (USD Billion, 2019-2032)

• Software


• Services


• Hardware

Clinical Decision Support System Product Outlook (USD Billion, 2019-2032)

• Integrated CDSS


• Standalone CDSS


• Treatment

Clinical Decision Support System Model Outlook (USD Billion, 2019-2032)

• Knowledge-Based CDSS


• Non-Knowledge-Based CDSS

Clinical Decision Support System Delivery Mode Outlook (USD Billion, 2019-2032)

• On-Premise CDSS


• Cloud-Based CDSS

Clinical Decision Support System Mode of Advice Outlook (USD Billion, 2019-2032)

• Active CDSS


• Passive CDSS

Clinical Decision Support System Setting Outlook (USD Billion, 2019-2032)

• Inpatient Settings


• Ambulatory Care Settings

Clinical Decision Support System Type Outlook (USD Billion, 2019-2032)

• Therapeutic Clinical Decision Support Systems


• Diagnostic Clinical Decision Support Systems 

Clinical Decision Support System Application Outlook (USD Billion, 2019-2032)

• Advanced Clinical Decision Support Systems


• Conventional Clinical Decision Support Systems

Clinical Decision Support System Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America